Wolverine Trading
MRTX

Wolverine Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Wolverine Trading’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,000
Closed -$705K – 5512
2023
Q4 		$705K Sell
12,000
-5,200
-30% -$292K ﹤0.01% 2609
2023
Q3 		$749K Buy
17,200
+8,700
+102% +$311K ﹤0.01% 2372
2023
Q2 		$310K Buy
+8,500
New +$350K ﹤0.01% 3056
2023
Q1 		– Sell
-10,500
Closed -$476K – 5164
2022
Q4 		$476K Buy
+10,500
New +$680K ﹤0.01% 2377
2022
Q3 		– Sell
-3,700
Closed -$249K – 5569
2022
Q2 		$249K Sell
3,700
-700
-16% -$44.5K ﹤0.01% 3294
2022
Q1 		$366K Sell
4,400
-400
-8% -$40.9K ﹤0.01% 3657
2021
Q4 		$712K Sell
4,800
-400
-8% -$62.1K ﹤0.01% 3016
2021
Q3 		$906K Buy
5,200
+3,900
+300% +$627K ﹤0.01% 3111
2021
Q2 		$211K Buy
+1,300
New +$209K ﹤0.01% 4952

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wolverine Trading's MRTX Position: Q1 2022 in Review

Wolverine Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2022, closing a stake of 1,600 shares — an estimated $164K sold.

Wolverine Trading first reported a position in MRTX in Q4 2021 and held it in 1 quarter. The position peaked at $237K in Q4 2021. 253 funds tracked by Wall St. Rank hold MRTX as of Q1 2022.

  • Wolverine Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 1,600 Mirati Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $164K.
  • Wolverine Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Wolverine Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $237K in Q4 2021.
  • 253 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.